Navigation Links
Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease

ent increase in GCase levels was observed in white blood cells from healthy volunteers receiving Plicera.

Phase 2 Clinical Trials of Plicera in Gaucher Disease

Based on the Phase 1 results, Amicus has initiated two Phase 2 clinical trials of Plicera for Gaucher disease. One is a 4-week study designed to evaluate the safety and pharmacodynamic effects of Plicera in Type I Gaucher patients who will discontinue enzyme replacement therapy for the duration of the study. The second is a 6-month study designed to evaluate the safety of Plicera and its effect on parameters that are commonly abnormal in Gaucher disease. This study will be conducted in Type I Gaucher patients who have never received enzyme replacement therapy. More information regarding these studies can be found at www.clinicaltrials.gov and www.amicustherapeutics.com.

About Gaucher Disease

Gaucher disease, the most commonly diagnosed lysosomal storage disorder, is caused by inherited genetic mutations in the GBA gene, which result in deficient activity of the enzyme acid beta-glucosidase, also known as glucocerebrosidase (GCase). Deficient GCase activity leads to lysosomal accumulation of glucocerebroside inside certain cells, which is believed to cause the various symptoms of Gaucher disease, including an enlarged liver and spleen, abnormally low levels of red blood cells and platelets and skeletal complications. In some cases there is significant impairment of the central nervous system. Gaucher disease affects an estimated 8,000 to 10,000 people worldwide. The U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for the active ingredient in Plicera in the United States.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics
'"/>




Page: 1 2 3

Related medicine technology :

1. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ... recently closed a bridge loan financing (the "2009 ... Purchase Agreement (the "Agreement") with Firebird Global Master ... Company sold a convertible promissory note, due June ... US$1,400,000, and issued a warrant to purchase an ...
(Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
(Date:12/16/2009)... -- Greenway Medical Technologies, Inc. today announced that ... practice management and interoperability solution, Prime Suite® ... the annual 2009 Top 20 Best in ... report. ,, For practices having between six and ... Best in KLAS in ambulatory EMR for the ...
Breaking Medicine Technology:AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 1Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 2Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 3Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 4NovaBay 28R 29 Pharmaceuticals Names Roy J Wu as Senior Vice President for Business Development 13326 1NovaBay 28R 29 Pharmaceuticals Names Roy J Wu as Senior Vice President for Business Development 13326 2NovaBay 28R 29 Pharmaceuticals Names Roy J Wu as Senior Vice President for Business Development 13326 3Blood Type May Boost Pancreatic Cancer Risk 53472 1Blood Type May Boost Pancreatic Cancer Risk 53472 2
(Date:12/16/2009)... from Episencial Offers Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging ... ... Los Angeles, CA (PRWEB) December 16, 2009 -- ... affordable choice in all natural skin care for their children ... for young children featuring the beloved artwork of The Very ...
(Date:12/16/2009)... caution, though, that no direct link has been found, ... bacteria in food -- commonly linked to food poisoning ... might also be the cause of some urinary tract ... the bacteria in chicken from stores and restaurants and ... evidence that the germs were transmitted directly to the ...
(Date:12/16/2009)... and MassBio promote Massachusetts companies through annual marketing campaign ... ... 2009 -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , , ,Genetown is sponsored by MassBio ... device industries. The campaign places each entity’s brand on an ...
(Date:12/16/2009)... Deaths also at all-time low, government report shows, , , ... in the United States has reached almost 78 years, ... From birth in 2007, women can expect to live ... years, according to the report from the U.S. Centers ... though Americans can expect to live longer than their ...
(Date:12/16/2009)... travel facilitator Companion Global Healthcare Inc. has accepted ... network of international hospitals that treat American patients ... U.S. facilities. ,, The announcement means Companion Global ... pricing for its individual clients and employer group ... Pablo Bayamon or HIMA San Pablo Caguas. ,, ...
Breaking Medicine News(10 mins):Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:Thriving Bioscience Region Leaves Its Mark 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2
... Just last spring,SafeSmart, Inc. launched SafetyTies, antimicrobial ... and food-borne illness. Already, the medical,marketplace is ... illness,prevention, thanks to its participation in the ... St. Louis, October 2007. Headquartered in ...
... object, but these noises may boost fitness , , WEDNESDAY, Oct. 24 ... is honest about it: When exercising, she sometimes grunts. , "I ... during a workout, and I think that most people do," said ... it,s a release." , But not everyone is so accepting ...
... AIGISRx DEB is designed to reduce the severity of capsular ... ... capsule formation, MONMOUTH ... the commercialization of implantable medical-pharmaceutical,devices, announced today acceptance for presentation ...
... shortage ... facing the industry, SOUTH BEND, Ind., ... and recognition for work done,as the top areas hospitals need to ... on American Health Care.,The report was released today by Press Ganey ...
... 24 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ), a ... and high intensity focused ultrasound tumor,therapy systems, today announced the following investor events: ... ... Location UBS ...
... Can be Achieved ... Without Fear of Side Effects, LONDON, October 24 ... new study published in the,International Journal of Impotence Research reveals (1). ... performance, these,categories, do not reveal the qualities, benefits or even disappointments,for ...
Other Medicine News:Health News:SafeSmart, Inc. Presents SafetyTies to Sixth Annual MedAssets Technology Forum 2Health News:Experts Sound Off on Workout Grunting 2Health News:Experts Sound Off on Workout Grunting 3Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 2Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 3Health News:Nurses and Hospital Employees' Top Concerns: Communication, Staffing and Compensation 2Health News:China Medical Technologies to Participate in Investor Events in November 2Health News:Now Every Man Can Enhance His Performance, Whatever His Sexual Style 2
... first contact the diamond shaped teeth set the blade ... Because the teeth are very sharp, and the cut ... bone is cut with minimal force due to the ... , ,The troughs between ...
... system, offers precision with ease of ... The system can be utilized for ... maxillofacial, podiatric and otology techniques. The ... high speed drill, low speed drill, ...
The High Speed Drill handpiece is a well-balanced, high performance drill that provides high speed for,bone sculpting, along with power for difficult osteotomies. Also available in a throttleless mod...
... with hand throttle. Accepts all 1000 and ... air hose 9000-000, or existing hose with ... 9013-000, or existing hose with Linvatec/Hall connector ... existing hose with 3M connector (1000-300). , ...
Medicine Products: